105 related articles for article (PubMed ID: 18161531)
1. Simultaneous analysis of in vivo CD8+ T cell cytotoxicity against multiple epitopes using multicolor flow cytometry.
Fuse S; Usherwood E
Immunol Invest; 2007; 36(5-6):829-45. PubMed ID: 18161531
[TBL] [Abstract][Full Text] [Related]
2. Fluorescent antigen-transfected target cell cytotoxic T lymphocyte assay for ex vivo detection of antigen-specific cell-mediated cytotoxicity.
van Baalen CA; Kwa D; Verschuren EJ; Reedijk ML; Boon AC; de Mutsert G; Rimmelzwaan GF; Osterhaus AD; Gruters RA
J Infect Dis; 2005 Oct; 192(7):1183-90. PubMed ID: 16136460
[TBL] [Abstract][Full Text] [Related]
3. A sensitive flow cytometry-based cytotoxic T-lymphocyte assay through detection of cleaved caspase 3 in target cells.
He L; Hakimi J; Salha D; Miron I; Dunn P; Radvanyi L
J Immunol Methods; 2005 Sep; 304(1-2):43-59. PubMed ID: 16076473
[TBL] [Abstract][Full Text] [Related]
4. The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo.
Hermans IF; Silk JD; Yang J; Palmowski MJ; Gileadi U; McCarthy C; Salio M; Ronchese F; Cerundolo V
J Immunol Methods; 2004 Feb; 285(1):25-40. PubMed ID: 14871532
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the CD107 cytotoxicity assay for the detection of cytolytic CD8+ cells recognizing HER2/neu vaccine peptides.
Mittendorf EA; Storrer CE; Shriver CD; Ponniah S; Peoples GE
Breast Cancer Res Treat; 2005 Jul; 92(1):85-93. PubMed ID: 15980996
[TBL] [Abstract][Full Text] [Related]
6. A flow cytometry-based assay to assess minute frequencies of CD8+ T cells by their cytolytic function.
Stanke J; Hoffmann C; Erben U; von Keyserling H; Stevanovic S; Cichon G; Schneider A; Kaufmann AM
J Immunol Methods; 2010 Aug; 360(1-2):56-65. PubMed ID: 20558172
[TBL] [Abstract][Full Text] [Related]
7. Development of highly sensitive Bicistronic vector based non-radioactive antigen-specific cytotoxicity assay.
Gupta P; Tayal R; Durgapal H; Rath S; Acharya SK; Panda SK
J Immunol Methods; 2009 Sep; 349(1-2):28-37. PubMed ID: 19682994
[TBL] [Abstract][Full Text] [Related]
8. Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2.
Mochimaru H; Usui T; Yaguchi T; Nagahama Y; Hasegawa G; Usui Y; Shimmura S; Tsubota K; Amano S; Kawakami Y; Ishida S
Invest Ophthalmol Vis Sci; 2008 May; 49(5):2172-7. PubMed ID: 18263815
[TBL] [Abstract][Full Text] [Related]
9. High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals.
Forsberg O; Carlsson B; Malmström PU; Ullenhag G; Tötterman TH; Essand M
Prostate; 2009 Jan; 69(1):70-81. PubMed ID: 18814178
[TBL] [Abstract][Full Text] [Related]
10. Capture of membrane components via trogocytosis occurs in vivo during both dendritic cells and target cells encounter by CD8(+) T cells.
Riond J; Elhmouzi J; Hudrisier D; Gairin JE
Scand J Immunol; 2007 Oct; 66(4):441-50. PubMed ID: 17850589
[TBL] [Abstract][Full Text] [Related]
11. LiveCount Assay: concomitant measurement of cytolytic activity and phenotypic characterisation of CD8(+) T-cells by flow cytometry.
Devêvre E; Romero P; Mahnke YD
J Immunol Methods; 2006 Apr; 311(1-2):31-46. PubMed ID: 16527300
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and functional analysis of LCMV gp33-41-specific CD8 T cells elicited by multiple peptide immunization in mice revealed the up-regulation of PD-1 expression on antigen-specific CD8 T cells.
Liu Y; Xu L; Jiang Y; Sun J; He X
Cell Mol Immunol; 2007 Dec; 4(6):431-7. PubMed ID: 18163954
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
14. The magnitude of the CD8+ T cell response produced by recombinant virus vectors is a function of both the antigen and the vector.
Millar J; Dissanayake D; Yang TC; Grinshtein N; Evelegh C; Wan Y; Bramson J
Cell Immunol; 2007; 250(1-2):55-67. PubMed ID: 18313652
[TBL] [Abstract][Full Text] [Related]
15. CD8beta knockout mice mount normal anti-viral CD8+ T cell responses--but why?
Angelov GS; Guillaume P; Luescher IF
Int Immunol; 2009 Feb; 21(2):123-35. PubMed ID: 19088062
[TBL] [Abstract][Full Text] [Related]
16. The level of friend retrovirus replication determines the cytolytic pathway of CD8+ T-cell-mediated pathogen control.
Zelinskyy G; Balkow S; Schimmer S; Werner T; Simon MM; Dittmer U
J Virol; 2007 Nov; 81(21):11881-90. PubMed ID: 17728236
[TBL] [Abstract][Full Text] [Related]
17. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo measurement of the cytotoxic capacity of human primary antigen-specific CD8 T cells.
Mbitikon-Kobo FM; Bonneville M; Sekaly RP; Trautmann L
J Immunol Methods; 2012 Jan; 375(1-2):252-7. PubMed ID: 21996428
[TBL] [Abstract][Full Text] [Related]
19. Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination.
Kastenmuller W; Gasteiger G; Gronau JH; Baier R; Ljapoci R; Busch DH; Drexler I
J Exp Med; 2007 Sep; 204(9):2187-98. PubMed ID: 17709425
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
Kim S; Lee JB; Lee GK; Chang J
Prostate; 2009 Jun; 69(9):938-48. PubMed ID: 19267351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
